StonvexLoading…
StonvexStonvexStonvexCore line items from BTBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-12-29 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $14.82M | $14.08M | $14.08M | $12.60M |
Operating Income | $-1.83M | $-1.07M | $-1.07M | $-391.16K |
Net Income | $-2.31M | $-887.37K | $-887.37K | $-562.28K |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | Not available | $14.61M | Not available | $16.77M |
Total Liabilities | Not available | $5.42M | Not available | $6.62M |
Cash & Equivalents | $1.95M | $5.30M | Not available | $2.15M |
Free Cash Flow OCF − CapEx | $-1.22M | $-747.17K | Not available | $-266.60K |
Shares Outstanding | 6.15M | 6.25M | Not available | 6.40M |